Improving the quality of life of care home residents with dementia: Cost-effectiveness of an optimized intervention for residents with clinically significant agitation in dementia.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
02 2019
Historique:
received: 18 02 2018
revised: 18 05 2018
accepted: 21 08 2018
pubmed: 25 11 2018
medline: 11 4 2020
entrez: 25 11 2018
Statut: ppublish

Résumé

To examine whether an optimized intervention is a more cost-effective option than treatment as usual (TAU) for improving agitation and quality of life in nursing home residents with clinically significant agitation and dementia. A cost-effectiveness analysis within a cluster-randomized factorial study in 69 care homes with 549 residents was conducted. Each cluster was randomized to receive either the Well-being and Health for people with Dementia (WHELD) intervention or TAU for nine months. Health and social care costs, agitation, and quality of life outcomes were evaluated. Improvements in agitation and quality of life were evident in residents allocated to the WHELD intervention group. The additional cost of the WHELD intervention was offset by the higher health and social care costs incurred by TAU group residents (mean difference, £2103; 95% confidence interval, -13 to 4219). The WHELD intervention has clinical and economic benefits when used in residents with clinically significant agitation.

Identifiants

pubmed: 30470592
pii: S1552-5260(18)33519-2
doi: 10.1016/j.jalz.2018.08.010
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

282-291

Subventions

Organisme : Department of Health
ID : RP-PG-0608-10133
Pays : United Kingdom

Informations de copyright

Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Auteurs

Renee Romeo (R)

Health Service and Population Research Department, King's College London, institute of Psychiatry, Psychology and Neuroscience, London, UK. Electronic address: renee.romeo@kcl.ac.uk.

Darshan Zala (D)

Health Service and Population Research Department, King's College London, institute of Psychiatry, Psychology and Neuroscience, London, UK.

Martin Knapp (M)

Personal Social Services Research Unit, London School of Economics and Political Science, London, UK.

Martin Orrell (M)

Institute of Mental Health, University of Nottingham, Innovation Park, Nottingham, UK.

Jane Fossey (J)

Psychological Services, Oxford Health NHS Foundation Trust, Fulbrook Centre, Oxford, UK.

Clive Ballard (C)

Wolfson Centre for Age Related Diseases, King's College London, Guy's Campus, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH